CN114146014B - 一种复方烟酸薄荷酯植物多糖乳膏及其制备方法 - Google Patents
一种复方烟酸薄荷酯植物多糖乳膏及其制备方法 Download PDFInfo
- Publication number
- CN114146014B CN114146014B CN202111492588.3A CN202111492588A CN114146014B CN 114146014 B CN114146014 B CN 114146014B CN 202111492588 A CN202111492588 A CN 202111492588A CN 114146014 B CN114146014 B CN 114146014B
- Authority
- CN
- China
- Prior art keywords
- extract
- oil
- polysaccharide
- percent
- menthyl nicotinate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Reproductive Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种复方烟酸薄荷酯植物多糖乳膏,以质量百分比计,包括以下原料:烟酸薄荷酯1.0%‑1.5%、紫草油7%‑10%、石榴籽油0.5%‑1.5%、摩洛哥坚果油1.0%‑1.5%、多糖提取液2%‑5%、中药材提取物3%‑6%和助剂11.5%‑12.5%,余量为去离子水;制备方法:(1)称取各原料;(2)将烟酸薄荷酯、紫草油、石榴籽油、摩洛哥坚果油和助剂预热,熔化,得到油相;(3)将多糖提取液和中药材提取物加入去离子水中,溶解,得到水相;(4)将油相和水相进行均质乳化,降至室温,静置后灌装,即得。本发明乳膏具有抗菌消炎、美肤抗皱、镇痛止痒、灭疣消瘢之功效,可广泛应用于皮肤的养护和治疗。
Description
技术领域
本发明涉及药物化妆品配方和制备技术领域,更具体的说是涉及一种复方烟酸薄荷酯植物多糖乳膏配方的创新及其制备方法的研究。
背景技术
随着社会经济的不断进步和物质生活的丰富,被称作“美丽的经济”的化妆品从简单的数量扩张到结构优化转变,享受健康、环保的低碳生活已成为国内越来越多消费者的共识。顺应这种环保潮流,在护肤品的生产和使用上追求自然、绿色,环保已成为护肤品行业的必然发展趋势。
近几年来,纯天然产品、有机产品备受追捧,是未来护肤品市场的一个发展热点,也是各护肤品企业加强研发的重点领域。尤其是添加活性皮肤微循环和天然中草药、多糖,具有美容和治疗功效,类似药物特性的活性产品,近年来逐渐成为化妆品市场的主流。
因此,如何提供一种功效优异,实用、功能多重的优质护肤品是本领域技术人员亟需解决的问题。
发明内容
有鉴于此,本发明的目的在于提供一种复方烟酸薄荷酯植物多糖乳膏及其制备方法,为消费者提供一种功效优异,实用、功能多重的优质护肤品。
为了实现上述目的,本发明采用如下技术方案:
一种复方烟酸薄荷酯植物多糖乳膏,以质量百分比计,包括以下原料:烟酸薄荷酯1.0%-1.5%、紫草油7%-10%、石榴籽油0.5%-1.5%、摩洛哥坚果油1.0%-1.5%、多糖提取液2%-5%、中药材提取物3%-6%和助剂11.5%-12.5%,余量为去离子水。
药物化妆品的美容应用是中国医学外治方法之一。从现代医学的观点看,是通过有效成分的透皮吸收,改善皮肤的微循环状况,增强皮肤保持旺盛的抗病和修复能力,以达到延缓皮肤衰老为目的。
本发明选用了以烟酸薄荷酯为首,以紫草油、石榴籽油、摩洛哥坚果油、多糖提取液以及紫草、三七、金银花、白蔹、白鲜皮、当归和黄芪等中草药提取物为辅,赋予了产品协同具有活血镇痛、祛风除湿、抑制细菌生长、抗炎镇痛、软化疙瘩、抑制疤痕增生以及促进皮肤血液循环,增加皮肤弹性、抑制黑色素产生之功效。
本发明乳膏选用了温和的油料和助剂做基质,使得产品适用性更加广泛、老幼妇孺皆可使用。
本发明中,烟酸薄荷酯是薄荷醇和烟酸反应生成的酯,分子式为C16H23NO2,作为药品可防治皮肤病和类似的维生素缺乏症,具有扩张血管的作用,医治末梢神经痉挛、动脉硬化等,故有散发作用。
本发明复方烟酸薄荷酯植物多糖乳膏的优异性能在于配方中烟酸薄荷酯的加入,烟酸薄荷酯是薄荷醇和烟酸的酯,是一种薄荷衍生物。
烟酸薄荷酯是一种酯,也是一种长效无味的清凉剂,有轻微的薄荷香气,尝起来几乎没有味道,但伴有持久的、令人愉快的清凉效果,被认定为极好的、没有不良反应(如灼烧感、刺激感和刺痛感)的清凉剂。烟酸薄荷酯是复方烟酸薄荷酯植物多糖乳膏中的活性成分,用于治疗蜂窝组织炎症(一种皮肤伤口的细菌感染,当细菌感染已经侵犯到皮肤皮下脂肪层,因为皮下脂肪本身的排列方式就有点像蜂窝)活化皮肤微循环、是局部消炎镇痛的酯化物。
人缺乏烟酸将产生糙皮病(也称癞皮病)。烟酸薄荷酯是一种酯,性能温和、无味、无刺激,比烟酸有更好的亲肤性能兼有烟酸活化皮肤细胞、快速修复皮肤损伤、抗皱美肤和薄荷清凉、止疼止痒的双重功效,又规避了烟酸霜膏在使用过程中,导致皮肤油腻不适、毛孔堵塞以及薄荷本身的气味强烈、且清凉短促的副作用。
薄荷味辛,性凉。归肺、肝经。具有疏散风热,清头脑,利咽喉,透疹止痒作用。也可用于麻疹及风疹,透发不畅,皮肤瘙痒等症;外用能使粘膜血管收缩,感觉神经麻痹而产生清凉,止疼止痒作用。清凉型产品一般采用薄荷清作凉剂。但薄荷的挥发性和刺激性很大,导致清凉效果强烈而短促,而且特殊的薄荷味,会遮盖膏体应有的香气。
烟酸薄荷酯在本发明产品的使用,使得产品既具有烟酸抗癞皮、治疗皮肤蜂窝组织感染,修复皮肤组织损伤的功效,又兼备了薄荷透疹止痒的功能。也满足了产品清凉香气的需求。
其次,紫草的油浸提取物-紫草油在膏霜里的作用是凉血活血、解毒透疹,用于治疗温毒发斑、虚热毒甚、皮肤出现紫黑斑疹等皮肤疾病;紫草清热解毒、化瘀消肿,可用来除去痤疮。
石榴籽油具有很强清除人体自由基和延缓衰老的能力。将石榴籽油加入到化妆品中具有美白、去皱、延缓衰老的作用。石榴籽油也含有多种维生素,可抑制细菌生长,可以有效的促进细胞的新陈代谢。
摩洛哥坚果油近几年被广泛使用,这是一种从摩洛哥的阿甘树上坚果中提取的物质,因为拥有卓越的功效,所以又被称之为液体黄金,虽然是从坚果中生榨出来的果油,长期使用效果突出。摩洛哥坚果油中因为含有了大量的维生素E以及对皮肤有益的脂肪酸等成分,所以在肌肤上使用之后,就可以起到美容护肤的功效,长期使用能看到肌肤会十分的光滑细腻,它能帮助排除毛孔中的有毒物质,使肌肤干净亮白,还能有效的帮助肌肤起到抗氧化的作用。
进一步,上述多糖提取液为积雪草多糖提取液、银耳多糖提取液、白芨浸膏、马齿菜多糖提取液和海藻多糖中的至少一种。
采用上述进一步技术方案的有益效果在于,本发明所选多糖能够缓解刺激并具有保湿、抗衰老、修复皮肤组织、促进皮肤血液循环、抗疱疹的特性,适用性广泛,止痒迅速、安全性高。
其中,积雪草多糖的主要成分是积雪草总甙,在化妆品中应用于促进皮肤损伤愈合、治疗皮肤硬皮症、溃疡、瘢痕疙瘩、痤疮及瘘。对烧伤、烫伤、化学品及日光灼伤等有一定的疗效。
银耳多糖是银耳的主要成分。在本发明配方中能起到修复皮肤、增加表层皮肤水分、增强皮肤自我保护屏障、活化皮肤表皮细胞、保持皮肤的嫩滑和湿润,修复由于紫外线光照而皮肤损伤、从而达到消除皱纹,保持皮肤年轻态的功效。
白芨多糖可以美白祛斑、杀菌消炎、抗皱防衰。
马齿笕多糖具有消炎杀菌、修复细胞的作用,其次对于痤疮、疖、痈、蚊虫咬伤、湿疹丹毒等皮肤病有一定的疗效;
海藻多糖是一种优良的润肤剂。海藻糖有很好的保湿、美白、消除痤疮、修复身体细胞的损伤,去除疤痕和斑点效果。它不仅可以补充水分,还可以锁住水分,防止水分流失。其次,天然海藻也有控油的作用。海藻能增加皮肤紧致度,调节干性和油性皮肤,并使其尽可能与皮肤一致中性状态。
进一步,上述中药材提取物为三七提取物、金银花提取物、白蔹提取物、白鲜皮提取物、当归提取物和黄芪提取物中的至少一种。
采用上述进一步的有益效果在于,三七的作用是止血、散瘀、消肿定痛;改善和加强冠脉微循环;抗炎、抗疲劳;抗肿瘤、镇痛;用于各种内、外出血,胸腹刺痛,跌打肿痛。
金银花、白蔹、白鲜皮、当归和黄芪等中草药均具有养颜美容、淡化雀斑、色斑以及痤疮等所留下的疤痕,预防皮肤细菌、真菌等的感染,预防毛囊炎、皮炎、湿疹、真菌性皮肤癣,抗氧化、改善血液微循环、延缓衰老、祛除皱纹等功效。
进一步,上述助剂为硬脂酸甘油酯、聚氧乙烯羊毛醇醚、鲸蜡、乙酰化羊毛脂和辅助乳化剂中的至少一种。
本发明复方烟酸薄荷酯植物多糖乳膏,除具有普通乳液所具有的护肤、养肤功能之外,新赋予了产品综合优异功效:
1、烟酸薄荷酯活化皮肤微循环、预防和治疗人体蜂窝组织发炎;
2、银耳多糖的嫩滑润湿皮肤、消除皱纹;
3、积雪多糖的消除瘢痕促进创伤愈合;
4、马齿菜多糖修复细胞损伤、抗菌消炎、延缓衰老;
5、海藻多糖的消除痤疮,去除疤痕和斑点;
6、中草药金银花所具有的美容养颜、预防皮肤细菌、真菌感染、祛除皱纹延缓衰老;
7、紫草的清热解毒、活血消肿、透疹消斑、可以用于治疗烧伤、烫伤、疮毒等症;
8、白蔹、白鲜皮和黄芪等中草药的清热解毒,灭疣消瘢协同之功效。
本发明的创新点是:在于烟酸薄荷酯在配方中的添加;在于加入植物多糖乳和中草药提取物的加入,使得烟酸薄荷酯植物多糖乳膏趋于天然,使用性和功能性相结合;以局部皮肤治疗和养护相结合;能够达到标本兼治、人体内外兼治或由外养内的目的。
鉴于复方烟酸薄荷酯植物多糖乳膏的优异抗菌消炎、美肤抗皱、镇痛止痒、灭疣消瘢之功效,可广泛应用于皮肤的养护和治疗;鉴于乳膏采用优异的基质原料构成,乳膏具有优良的皮肤亲和力、柔和无味、润泽无刺激,适用于包括孕妇在内的各个群体,而且可以大面积使用;也可用于皮肤粘膜处作痔疮膏,亦可适宜轻度妇科炎症的外用。
一种复方烟酸薄荷酯植物多糖乳膏的制备方法,具体包括以下步骤:
(1)按上述复方烟酸薄荷酯植物多糖乳膏的质量百分比称取各原料;
(2)将烟酸薄荷酯、紫草油、石榴籽油、摩洛哥坚果油和助剂加入预热罐中进行预热,待开始熔化时开动搅拌至完全熔化,得到油相;
(3)将多糖提取液和中药材提取物加入去离子水中,加热搅拌使溶解完全,得到水相;
(4)将油相和水相通过带过滤网的管路压入均质乳化器中,开启搅拌进行均质乳化,然后降至室温,静置后灌装,即得所述复方烟酸薄荷酯植物多糖乳膏。
进一步,上述步骤(2)中,预热的温度为70-80℃。
进一步,上述步骤(4)中,搅拌的时间为2h;静置的时间为24h。
综上所述的技术方案可知,与现有技术相比,本发明复方烟酸薄荷酯植物多糖乳膏的有益效果如下:
1、具有抗菌消炎、美肤抗皱、镇痛止痒、灭疣消瘢之功效,可广泛应用于皮肤的养护和治疗;
2、采用优异的基质原料构成,赋予了乳膏优良的皮肤亲和力、柔和无味、润泽无刺激,适用于包括孕妇在内的各个群体,而且可以大面积使用;
3、可用于皮肤粘膜处作痔疮膏,亦可适宜轻度妇科炎症的外用;
4、抵抗过敏,适用于敏感性皮肤。
具体实施方式
下面对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
复方烟酸薄荷酯植物多糖乳膏,包括以下原料:烟酸薄荷酯1.0g、11号白油浸提紫草油10g、石榴籽油0.5g、摩洛哥坚果油1.0g、硬脂酸甘油酯2.5g、聚氧乙烯羊毛醇醚2g、鲸蜡5g、乙酰化羊毛脂2g、辅助乳化剂1.0g、积雪草多糖提取液0.5g、银耳多糖提取液1.0g、白芨浸膏1.0g、马齿菜多糖提取液1.0g、海藻多糖1.5g、中药材提取物(三七粉、金银花、白蔹、白鲜皮、当归和黄芪)3g和去离子水67.0g;
上述复方烟酸薄荷酯植物多糖乳膏的制备方法,具体包括以下步骤:
(1)按上述复方烟酸薄荷酯植物多糖乳膏的质量称取各原料;
(2)将烟酸薄荷酯、11号白油浸提紫草油、石榴籽油、摩洛哥坚果油、硬脂酸甘油酯、聚氧乙烯羊毛醇醚、鲸蜡、乙酰化羊毛脂和辅助乳化剂加入预热罐中进行75℃预热,待开始熔化时开动搅拌至完全熔化,得到油相;
(3)将积雪草多糖提取液、银耳多糖提取液、白芨浸膏、马齿菜多糖提取液、海藻多糖、中药材提取物(三七粉、金银花、白蔹、白鲜皮、当归和黄芪)加入去离子水中,加热搅拌使溶解完全,得到水相;
(4)保持上述油相和水相的温度,将油相和水相通过带过滤网的管路压入均质乳化器中,开启搅拌进行均质乳化2h,然后降至室温,静置24h后灌装,即得复方烟酸薄荷酯植物多糖乳膏。
实施例2
复方烟酸薄荷酯植物多糖乳膏,包括以下原料:烟酸薄荷酯1.5g、11号白油浸提紫草油8g、石榴籽油1g、摩洛哥坚果油1.5g、硬脂酸甘油酯2.5g、聚氧乙烯羊毛醇醚2g、鲸蜡4g、乙酰化羊毛脂2g、辅助乳化剂1.0g、积雪草多糖提取液1.0g、银耳多糖提取液2.0g、白芨浸膏1.5g、马齿菜多糖提取液1.0g、海藻多糖2g、中药材提取物(三七粉、金银花、白蔹、白鲜皮、当归和黄芪)4g、去离子水65.0g;
上述复方烟酸薄荷酯植物多糖乳膏的制备方法,具体包括以下步骤:
(1)按上述复方烟酸薄荷酯植物多糖乳膏的质量称取各原料;
(2)将烟酸薄荷酯、11号白油浸提紫草油、石榴籽油、摩洛哥坚果油、硬脂酸甘油酯、聚氧乙烯羊毛醇醚、鲸蜡、乙酰化羊毛脂和辅助乳化剂加入预热罐中进行70℃预热,待开始熔化时开动搅拌至完全熔化,得到油相;
(3)将积雪草多糖提取液、银耳多糖提取液、白芨浸膏、马齿菜多糖提取液、海藻多糖、中药材提取物(三七粉、金银花、白蔹、白鲜皮、当归和黄芪)加入去离子水中,加热搅拌使溶解完全,得到水相;
(4)保持上述油相和水相的温度,将油相和水相通过带过滤网的管路压入均质乳化器中,开启搅拌进行均质乳化2h,然后降至室温,静置24h后灌装,即得复方烟酸薄荷酯植物多糖乳膏。
实施例3
复方烟酸薄荷酯植物多糖乳膏,包括以下原料:烟酸薄荷酯2.0g、11号白油浸提紫草油7g、石榴籽油1.5g、摩洛哥坚果油1.5g、硬脂酸甘油酯2.0g、聚氧乙烯羊毛醇醚3g、鲸蜡4g、乙酰化羊毛脂2g、辅助乳化剂1.0g(油相成分总量24.0g)、积雪草多糖提取液1.0g、银耳多糖提取液2.0g、白芨浸膏1.5g、马齿菜多糖提取液1.0g、海藻多糖2g、中药材提取物(三七粉、金银花、白蔹、白鲜皮、当归和黄芪)6g和去离子水62.5g;
上述复方烟酸薄荷酯植物多糖乳膏的制备方法,具体包括以下步骤:
(1)按上述复方烟酸薄荷酯植物多糖乳膏的质量称取各原料;
(2)将烟酸薄荷酯、11号白油浸提紫草油、石榴籽油、摩洛哥坚果油、硬脂酸甘油酯、聚氧乙烯羊毛醇醚、鲸蜡、乙酰化羊毛脂和辅助乳化剂加入预热罐中进行80℃预热,待开始熔化时开动搅拌至完全熔化,得到油相;
(3)将积雪草多糖提取液、银耳多糖提取液、白芨浸膏、马齿菜多糖提取液、海藻多糖、中药材提取物(三七粉、金银花、白蔹、白鲜皮、当归和黄芪)加入去离子水中,加热搅拌使溶解完全,得到水相;
(4)保持上述油相和水相的温度,将油相和水相通过带过滤网的管路压入均质乳化器中,开启搅拌进行均质乳化2h,然后降至室温,静置24h后灌装,即得复方烟酸薄荷酯植物多糖乳膏。
性能测试
1、指标测试
各取实施例1-3制得的复方烟酸薄荷酯植物多糖乳膏,按QB/T1857-2013化妆品膏霜标准进行性能检测。结果如表1所示。
表1 实施例1-3复方烟酸薄荷酯植物多糖乳膏指标测试结果
由表1可知,本发明实施例1-3复方烟酸薄荷酯植物多糖乳膏膏体细腻,易于涂展;清凉草药芳香;紫草油赋予的淡紫色;40℃±1/24h,恢复室温后无油水分离现象;-10℃±1/24h,恢复室温后无油水分离现象。
以上试验说明,本发明实施例1-3复方烟酸薄荷酯植物多糖乳膏的产品质量性能均能达到标准要求。
2、人体试验
各取实施例1-3制得的复方烟酸薄荷酯植物多糖乳膏,以涂抹皮肤或患处的方式使用。
使用方法为:取少许乳膏用指腹的力量,从中央轻轻向外按摩推开,直至被皮肤完全吸收。
使用结果:经各年龄段多人反复试用,反应良好,皆取得了的优良的效果。
以上试验说明,本发明以应用烟酸薄荷酯为主旨,辅以石榴籽油、多糖和紫草等中草药提取液制备的复方烟酸薄荷酯多糖乳膏,涉及到医药理论药品配伍和膏体基质配方两个方面,属于两个不同的技术领域。本发明复方烟酸薄荷酯植物多糖乳膏成功,为消费者在滋养皮肤、促进皮肤血液循环,防止皮肤衰老、内病外治,外病防治方面,发挥着独特的作用。它的研制成功,在为人民带来福音的同时,将会为企业创造出良好的经济效益和社会效益。
对所公开的实施例的上述说明,使本领域专业技术人员能够实现或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来说将是显而易见的,本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下,在其它实施例中实现。因此,本发明将不会被限制于本文所示的这些实施例,而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。
Claims (6)
1.一种复方烟酸薄荷酯植物多糖乳膏,其特征在于,以质量百分比计,包括以下原料:烟酸薄荷酯1.0%-1.5%、紫草油7%-10%、石榴籽油0.5%-1.5%、摩洛哥坚果油1.0%-1.5%、多糖提取液2%-5%、中药材提取物3%-6%和助剂11.5%-12.5%,余量为去离子水;
所述多糖提取液为积雪草多糖提取液、银耳多糖提取液、白芨浸膏、马齿菜多糖提取液和海藻多糖;
所述中药材提取物为三七提取物、金银花提取物、白蔹提取物、白鲜皮提取物、当归提取物和黄芪提取物。
2.根据权利要求1所述的一种复方烟酸薄荷酯植物多糖乳膏,其特征在于,所述助剂为硬脂酸甘油酯、聚氧乙烯羊毛醇醚、鲸蜡、乙酰化羊毛脂和辅助乳化剂中的至少一种。
3.一种复方烟酸薄荷酯植物多糖乳膏的制备方法,其特征在于,具体包括以下步骤:
(1)按权利要求1或2所述复方烟酸薄荷酯植物多糖乳膏的质量百分比称取各原料;
(2)将烟酸薄荷酯、紫草油、石榴籽油、摩洛哥坚果油和助剂加入预热罐中进行预热,待开始熔化时开动搅拌至完全熔化,得到油相;
(3)将多糖提取液和中药材提取物加入去离子水中,加热搅拌使溶解完全,得到水相;
(4)将油相和水相通过带过滤网的管路压入均质乳化器中,开启搅拌进行均质乳化,然后降至室温,静置后灌装,即得所述复方烟酸薄荷酯植物多糖乳膏。
4.根据权利要求3所述的一种复方烟酸薄荷酯植物多糖乳膏的制备方法,其特征在于,步骤(2)中,所述预热的温度为70-80℃。
5.根据权利要求3所述的一种复方烟酸薄荷酯植物多糖乳膏的制备方法,其特征在于,步骤(4)中,所述搅拌的时间为2h。
6.根据权利要求3所述的一种复方烟酸薄荷酯植物多糖乳膏的制备方法,其特征在于,步骤(4)中,所述静置的时间为24h。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111492588.3A CN114146014B (zh) | 2021-12-08 | 2021-12-08 | 一种复方烟酸薄荷酯植物多糖乳膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111492588.3A CN114146014B (zh) | 2021-12-08 | 2021-12-08 | 一种复方烟酸薄荷酯植物多糖乳膏及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114146014A CN114146014A (zh) | 2022-03-08 |
CN114146014B true CN114146014B (zh) | 2023-06-20 |
Family
ID=80453854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111492588.3A Active CN114146014B (zh) | 2021-12-08 | 2021-12-08 | 一种复方烟酸薄荷酯植物多糖乳膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114146014B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115227588B (zh) * | 2022-08-05 | 2023-10-31 | 温州医科大学慈溪生物医药研究院 | 一种用于皮肤暗斑防护的乳膏剂 |
CN115054571B (zh) * | 2022-08-05 | 2024-02-27 | 温州医科大学慈溪生物医药研究院 | 一种预防和治疗皮肤皲裂的制剂 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940289A (zh) * | 2015-06-29 | 2015-09-30 | 周建志 | 一种止痒中药凝胶 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0182635B1 (en) * | 1984-11-15 | 1989-05-31 | Nitto Denko Corporation | Composition for percutaneous administration |
CA2309373A1 (en) * | 1999-05-27 | 2000-11-27 | Johnson & Johnson Consumer Companies, Inc. | Novel topical formulations |
US6524594B1 (en) * | 1999-06-23 | 2003-02-25 | Johnson & Johnson Consumer Companies, Inc. | Foaming oil gel compositions |
GB201320932D0 (en) * | 2013-11-27 | 2014-01-08 | Futura Medical Dev Ltd | Topical pharmaceutical composition |
CN106806463A (zh) * | 2015-11-30 | 2017-06-09 | 朱延升 | 一种长效促消化清凉油 |
-
2021
- 2021-12-08 CN CN202111492588.3A patent/CN114146014B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940289A (zh) * | 2015-06-29 | 2015-09-30 | 周建志 | 一种止痒中药凝胶 |
Also Published As
Publication number | Publication date |
---|---|
CN114146014A (zh) | 2022-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5266318A (en) | Skin therapeutic mixture containing cold-processsed aloe vera extract, with yellow sap and aloin removed | |
CN105616283A (zh) | 一种植物精粹修护面霜 | |
US20130095196A1 (en) | Blended oil skin moisturizer and skin repairer | |
CN108938513B (zh) | 一种清肤祛痘美颜霜及其制备方法 | |
CN103751725A (zh) | 一种抗炎杀菌去痘美白的药物 | |
KR101206998B1 (ko) | 탈모방지 및 발모용 두피 케어 조성물 및 이를 이용한 헤어 제품 | |
CN105030621A (zh) | 一种保湿祛痘爽肤水及其制备方法 | |
CN114146014B (zh) | 一种复方烟酸薄荷酯植物多糖乳膏及其制备方法 | |
KR100990195B1 (ko) | 알레르기, 아토피성 피부질환 완화 천연 화장료 조성물 | |
KR100905386B1 (ko) | 생약추출물을 함유하는 아토피 피부용 한방화장료 조성물 | |
CN113018238A (zh) | 一种抑菌消炎清爽益肤的祛痘凝胶及其制备方法 | |
KR20130015339A (ko) | 여드름 치료용 크림 조성물 | |
CN112006958A (zh) | 脱毛膏及制备方法 | |
CN106511211B (zh) | 一种抗炎祛痘护肤乳液及其制备方法 | |
KR101196397B1 (ko) | 식물성 추출물을 이용한 피톤치트 생성 아토피 습진 완화 조성물의 제조방법 | |
KR101257435B1 (ko) | 세이지 추출물, 레몬밤 추출물, 우뭇가사리 추출물 및 양파 추출물을 유효성분으로 포함하는 아토피 피부 및 피부 자극 완화용 화장료 조성물 | |
CN104095783A (zh) | 一种中药消炎拔痘美容霜及其制备方法 | |
KR101280315B1 (ko) | 피톤치트 아토피 습진 완화 조성물의 제조방법 | |
CN113509426A (zh) | 一种具有修复妊娠纹和肥胖纹的植物提取复合物及其制备方法和应用 | |
CN112472629A (zh) | 一种高良姜草果防晒乳液及其制备方法 | |
CN115518127B (zh) | 一种抑菌抗炎消肿止痒乳膏及其制备方法 | |
CN106924134A (zh) | 一种中药美白淡斑霜及其制备方法 | |
CN106890120A (zh) | 一种中药美白淡斑乳及其制备方法 | |
CN106667852A (zh) | 一种中药祛痘霜及其制备方法 | |
CN110812377B (zh) | 一种痤疮治疗修复组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |